| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
OPERATING EXPENSES: | ||||||||
Research and development | ||||||||
32,747 | 32,350 | 23,941 | 19,214 | 16,897 | 11,471 | 0 | 0 | 0 |
General and administrative | ||||||||
16,573 | 13,232 | 9,961 | 7,265 | 3,482 | 2,047 | 0 | 0 | 0 |
Total operating expenses | ||||||||
49,320 | 45,582 | 33,902 | 26,479 | 20,379 | 13,518 | 0 | 0 | 0 |
LOSS FROM OPERATIONS | ||||||||
-49,320 | -45,582 | -33,902 | -26,479 | -20,379 | -13,518 | 0 | 0 | 0 |
OTHER INCOME (EXPENSE), NET: | ||||||||
Interest income (expense), net | ||||||||
216 | 93 | -211 | -829 | -1,362 | -1,642 | 0 | 0 | 0 |
Other income (expense) | ||||||||
0 | - | - | - | - | - | - | - | - |
Other expense | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Total other income (expense), net | ||||||||
168 | 69 | -698 | -1,689 | -2,537 | -3,003 | 0 | 0 | 0 |
Net loss | ||||||||
-49,152 | -45,513 | -34,600 | -28,168 | -22,916 | -16,521 | 0 | 0 | 0 |
Net loss attributable to common stockholders—basic | ||||||||
-49,152 | -45,513 | -34,600 | -28,168 | -22,916 | -16,521 | 0 | 0 | 0 |
Net loss attributable to common stockholders— diluted | ||||||||
0 | - | 0 | - | 0 | - | 0 | - | 0 |
Net loss per share attributable to common stockholders—basic and diluted | ||||||||
-0.59 | -0.74 | -0.63 | -0.60 | -1.58 | -1.22 | -0.78 | -0.58 | -0.43 |
Weighted-average common stock outstanding—basic and diluted | ||||||||
20,840 | 14,769 | 17,095 | 13,945 | 5,513 | 5,512 | 5,497 | 5,463 | 5,458 |